Fig. 1

Correlation of the different scores with the survival of lung cancer patients. A Kaplan–Meier survival analysis for lung cancer patients classified into high- or low-Stromal-score groups based on comparison with the median (p = 0.52 by log-rank test). B Kaplan–Meier survival analysis for lung cancer patients classified into high- or low-Immune-score groups based on comparison with the median (p = 0.72 by log-rank test). C Kaplan–Meier survival analysis for lung cancer patients classified into high- or low-ESTIMATE-score groups based on comparison with the median (p = 0.82 by log-rank test). D Disease free survival analysis for lung cancer patients classified into high- or low-Stromal-score groups based on comparison with the median (p = 0.43 by log-rank test). E Disease free survival analysis for lung cancer patients classified into high- or low-Immune-score groups based on comparison with the median (p = 0.60 by log-rank test). F Disease free survival analysis for lung cancer patients classified into high- or low-ESTIMATE-score groups based on comparison with the median (p = 0.82 by log-rank test)